Overview

The Effects of Esmolol on the Hemodynamic Response to Orotracheal Extubation

Status:
Recruiting
Trial end date:
2020-07-01
Target enrollment:
0
Participant gender:
All
Summary
Beta-blockers are useful tools for the prevention of hemodynamic instability in the manipulation of airways. The main objective of the present study is to evaluate the effectiveness of using esmolol in attenuating hemodynamic responses at the time of tracheal extubation, by assessing the incidence of tachycardia in relation to placebo.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Hospital de Base
Treatments:
Esmolol
Criteria
Inclusion Criteria:

- Patients aged between 18 and 60 years, electively scaled for surgery requiring general
anesthesia.

- Physical State 1, 2 or 3 of the American Society of Anesthesiology (ASA)

Exclusion Criteria:

- Patients with cardiac disease

- Patients with renal disease

- Patients with liver disease

- Patient with lung disease

- Patients using beta blockers or calcium channel blockers

- Patients who refuse to participate in the study after presenting the informed consent
form